1. Bagnulo DJ, Perez A, Barret S, Millar B, McElwain TJ (1985) High dose melphalan and autologous bone marrow transplantation for solid tumours of childhood. Eur Paediatr Haematol Oncol 2:129?133
2. Bermudez J, Boyle EA, Miner WD, Sanger GJ (1988) The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694. Br J Cancer 58:644?650
3. Bowman A, Allan SG, Leonard RCF, Scully N, Challoner T, Smyth JF (1988) The pharmacokinetics and antiemetic efficacy of the 5HT3 antagonist GR38032F at different doses and schedules in cisplatinum induced emesis. Abstract 250, 13th Congress of the European Society of Medical Oncology, October 30?November, 1988, Lugano, Switzerland
4. Brittain RT, Butler A, Coates IH, Future DH, Hasan R, Hill JM, Humber DC, Humphrey PP, Ireland SJ, Tack D, Jordan CC, Oxford A, Shaughan DW, Tyers MB (1987) GR38032F, a selective 5-HT3 receptor antagonist. Br. J. Pharmacol. 1987, 90: 87P
5. Cassidy J, Raina V, Lewis C, Adams L, Soukop M, Rapeport WG, Zussman BD, Rankin EM, Kaye SB (1988) Pharmacokinetics and anti-emetic efficacy of BRL 43694, a new selective 5HT-3 antagonist. Br J Cancer 58:651?653